Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
- Facilitation Desk
- Complaints

Home > News & Updates > Regulatory Updates > Drugs > The Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022 for comments

The Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022 for comments

Murtaza Awan Drugs January 5, 2022March 1, 2022QA & LT

The Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022

Word File Download

Share this:

Twitter
Facebook

← Draft Guidelines On Good Pharmacovigilance Practices For Registration Holders for view Comments to be Submitted to National PV Center DRAP till 15th January, 2022
Tender Documents For Purchase Of Pharmacy Refrigerators For DRAP →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem